Skip to search formSkip to main contentSkip to account menu

25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection [LipoDox]

Known as: DOXORUBICIN HYDROCHLORIDE 2 mg in 1 mL INTRAVENOUS INJECTABLE, LIPOSOMAL [LIPODOX 50], LIPODOX 50 MG in 25 ML Injection, LipoDox 50 MG per 25 ML Injection 
National Institutes of Health

Related topics

Related topics

12 relations
Ammonium SulfateCholesterolDoxorubicinDoxorubicin Hydrochloride

Broader (1)

doxorubicin liposome Injection [LipoDox]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363].
2012
2012
In Vivo Evaluation of Doxorubicin-Loaded (PEG)3-PLA Nanopolymersomes (PolyDoxSome) Using DMBA-Induced Mammary Carcinoma Rat Model and Comparison with Marketed LipoDox™
To evaluate in vivo doxorubicin-loaded (PEG)3-PLA nanopolymersomes (PolyDoxSome) using 7,12-dimethyl benz[α]anthracene (DMBA… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)